Nikolopoulos, P.; Liapis, G.; Giannakopoulos, P.; Kotsantis, I.; Drouzas, K.; Lionaki, S.
Rapidly Progressive Pauci-Immune Glomerulonephritis with Aberrant Fibrinoid Necrosis Associated with Atezolizumab, an Immune Check Point Inhibitor: A Case Report and Review of Literature. Antibodies 2023, 12, 10.
https://doi.org/10.3390/antib12010010
AMA Style
Nikolopoulos P, Liapis G, Giannakopoulos P, Kotsantis I, Drouzas K, Lionaki S.
Rapidly Progressive Pauci-Immune Glomerulonephritis with Aberrant Fibrinoid Necrosis Associated with Atezolizumab, an Immune Check Point Inhibitor: A Case Report and Review of Literature. Antibodies. 2023; 12(1):10.
https://doi.org/10.3390/antib12010010
Chicago/Turabian Style
Nikolopoulos, Petros, George Liapis, Panagiotis Giannakopoulos, Ioannis Kotsantis, Konstantinos Drouzas, and Sophia Lionaki.
2023. "Rapidly Progressive Pauci-Immune Glomerulonephritis with Aberrant Fibrinoid Necrosis Associated with Atezolizumab, an Immune Check Point Inhibitor: A Case Report and Review of Literature" Antibodies 12, no. 1: 10.
https://doi.org/10.3390/antib12010010
APA Style
Nikolopoulos, P., Liapis, G., Giannakopoulos, P., Kotsantis, I., Drouzas, K., & Lionaki, S.
(2023). Rapidly Progressive Pauci-Immune Glomerulonephritis with Aberrant Fibrinoid Necrosis Associated with Atezolizumab, an Immune Check Point Inhibitor: A Case Report and Review of Literature. Antibodies, 12(1), 10.
https://doi.org/10.3390/antib12010010
